考量流感重症病例數及流感住院人次仍多,故再次擴大公費流感抗病毒藥劑(下稱公費藥劑)使用條件「有類流感症狀,且家人/同事/同班同學有類流感發病者」,適用期限自即日起至7月31日止。
目前國內公費藥劑配置於各縣市衛生局規劃之全國約4000家合約醫療機構,配置藥劑包括克流感、易剋冒、速剋流及瑞樂沙。
若民眾有類流感症狀,除可用COVID-19家用快篩輔助檢測外,如有呼吸急促、呼吸困難、發紺、血痰、胸痛、意識改變、低血壓等危險徵兆應儘速就醫,並由醫師依主訴與臨床判斷,評估是否符合公費藥劑用藥條件,倘經判斷符合條件者,不需流感快篩,即可開立公費藥劑,以把握用藥時機。
![](https://lin-clinic-tw.com/wp-content/uploads/2024/07/流感藥物PDA-202008103_page-0001-scaled.jpg)
![](https://lin-clinic-tw.com/wp-content/uploads/2024/07/流感藥物PDA-202008103_page-0002-723x1024.jpg)
![](https://lin-clinic-tw.com/wp-content/uploads/2024/07/流感藥物PDA-202008103_page-0003-723x1024.jpg)
![](https://lin-clinic-tw.com/wp-content/uploads/2024/07/流感藥物PDA-202008103_page-0004-723x1024.jpg)
![](https://lin-clinic-tw.com/wp-content/uploads/2024/07/流感藥物PDA-202008103_page-0005-723x1024.jpg)
![](https://lin-clinic-tw.com/wp-content/uploads/2024/07/流感藥物PDA-202008103_page-0006-723x1024.jpg)